Medicare to Negotiate Prices for Ozempic, Wegovy, and 13 Other Drugs, Billions in Savings Expected
2025-01-17
Fortune
In a move that could lead to significant cost savings for taxpayers, Medicare has selected 15 drugs, including Ozempic and Wegovy, for the next round of price negotiations. This initiative is expected to result in billions of dollars in savings, providing relief to taxpayers and potentially lowering healthcare costs. The negotiation process aims to make prescription medications more affordable and accessible to those who need them, with popular keywords like 'prescription medication costs' and 'healthcare savings' being major points of discussion.
